INTRATHERAPEUTICS
IntraTherapeutics, Inc. is an emerging designer, manufacturer and marketer of peripheral stents, devices for the treatment of peripheral vascular diseases. The company's expanding line of products includes balloon-expandable non-coil stents or self-expandable coil and non-coil stents. IntraTherapeutics has a strong R&D pipeline and is in the process of introducing further products.
Similar Organizations
Chimeric Therapies
Chimeric Therapies is a Medical company.
Maritime International
Maritime International, Inc., a U.S. based privately owned marine fender systems company
Royce Laboratories, Inc.
Royce Laboratories, Inc. is a Medical company.
More informations about "IntraTherapeutics"
IntraTherapeutics - Crunchbase Company Profile & Funding
IntraTherapeutics, Inc. is an emerging designer, manufacturer and marketer of peripheral stents, devices for the treatment of peripheral vascular diseases. The company's expanding line of products includes balloon-expandable non-coil stents or self-expandable coil and non-coil …See details»
Intratherapeutics Inc - Company Profile and News
Company profile page for Intratherapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Sulzer Medica sees big growth in vascular treatments
Jan 5, 2001 IntraTherapeutics is a designer, manufacturer and marketer of peripheral stents – devices for treating peripheral vascular diseases. These are conditions in which the blood …See details»
IntraTherapeutics Company Profile 2024: Valuation, Investors ...
IntraTherapeutics General Information Description. Manufacturer of diagnostic and medical equipment. The company develops minimally invasive devices for diagnosis and treatment of …See details»
IntraTherapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore IntraTherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
IntraTherapeutics, Inc. - VentureRadar
IntraTherapeutics, Inc. VentureRadar profile. Find out more about IntraTherapeutics, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena …See details»
Intratherapeutics Cleared to Market New Stent
Jun 25, 1999 FDA has granted 510(k) market clearance to IntraTherapeutics Inc. (ITI; St. Paul, MN) for its IntraCoil self-expanding nitinol stent for the treatment of malignant bronchial …See details»
IntraTherapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. IntraTherapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»
Intra-Cellular Therapies
Our Mission. Our mission is to deliver innovative treatments to improve the lives of individuals with neuropsychiatric, neurologic, and other disorders to reduce the burden on patients and their …See details»
MFDA - Canadian Investment Regulatory Organization
September 29, 2022 (Toronto, Ontario) – Members of the Mutual Fund Dealers Association of Canada (MFDA) and the Investment Industry Regulatory Organization of Canada (IIROC) …See details»
The Right Play On Intra-Cellular Therapies - Seeking Alpha
Nov 20, 2023 Summary. Intra-Cellular Therapies, Inc. is a mid-cap biopharmaceutical company focused on developing treatments for neuropsychiatric and neurological disorders.See details»
Intra-Cellular Therapies - Crunchbase Company Profile & Funding
Intra-Cellular Therapies (ITI) develop new drugs for neuropsychiatric, neurologic diseases, and other Central Nervous System (CNS) disorders. The company integrates the work of medicinal …See details»
Intra-Cellular Therapies, Inc. (ITCI) - Stock Analysis
4 days ago About ITCI. Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that …See details»
Investment Industry Regulatory Organization of Canada (IIROC)
Canadian Investment Regulatory Organization (CIRO) is the recognized SRO to operate as a successor to the Investment Industry Regulatory Organization of Canada (IIROC) and the …See details»
Intra-Cellular Therapies Announces the Initiation of - GlobeNewswire
Dec 29, 2020 Intra-Cellular Therapies Announces the Initiation of Clinical Trials for ITI-LLAI, a Long-Acting Injectable Formulation of Lumateperone for the Treatment of Schizophrenia and …See details»
Intra-Cellular Therapies Announces Expansion of its Pipeline with …
Feb 24, 2021 ITI-1284 is a deuterated form of lumateperone delivered sublingually as an orally disintegrating tablet (ODT-SL). ITI-1284 ODT-SL may offer pharmacologic benefits and ease …See details»
New self-regulatory organization to replace IIROC and MFDA by …
Nov 24, 2021 The Canadian Securities Administrators (“CSA”) recently announced that the new self-regulatory organization (“New SRO”) that will consolidate the current functions of the …See details»
Medicines | Intracellular Therapies
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you …See details»
CSA to consolidate functions of IIROC and MFDA into a single self ...
Aug 9, 2021 On August 4, the Canadian Securities Administrators (CSA) published Position Paper 25-404 New Self-Regulatory Organization Framework (Position Paper), outlining their …See details»
Canada's securities regulators to create new watchdog body …
Aug 3, 2021 The umbrella organization for Canada's securities regulators says it plans to merge the regulatory bodies that oversee investment dealers and mutual fund dealers into one new …See details»